{"id":"dae0a13b1bfb","type":"article","url":"https://hartvaat.nl/2025/07/14/depressietrajecten-bij-hfpef-impact-op-uitkomsten/","title":"Depressietrajecten bij HFpEF: impact op uitkomsten","title_en":"Influence of depression trajectories in heart failure patients with preserved ejection fractions: a secondary analysis of adverse outcomes in the TOPCAT trial.","category":"hartfalen","category_label":"Hartfalen","professions":["cardioloog","huisarts"],"tags":[],"journal":"Heart (British Cardiac Society)","doi":"10.1136/heartjnl-2024-324505","source_url":"https://doi.org/10.1136/heartjnl-2024-324505","authors":["Fuwei Xing","Min Gao","Yuzhong Wu","Weihao Liang","Jingzhou Jiang","Yu-Gang Dong","Yi Li","Bin Dong","Chen Liu"],"significance":5,"published":"2025-07-14","source_date":"2025-07-14","image":"","kennis":[],"congress":"","summary_en":"Analysis of TOPCAT data documented the impact of depression trajectories on outcomes in HFpEF. Persistent depression was associated with significantly worse prognosis, supporting integrated mental health screening and care in heart failure management.","created":"2026-07-03T10:31:44Z","updated":"2026-07-03T13:30:44Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Studie documenteerde de impact van depressietrajecten op uitkomsten bij HFpEF. Persisterende depressie was geassocieerd met significant slechtere prognose, wat geïntegreerde mentale gezondheidszorg bij HFpEF ondersteunt.","abstract_original":"BACKGROUND: Long-term patterns of depressive symptoms among patients with heart failure, specifically those with a preserved ejection fraction (HFpEF), and their relationship with prognoses are not well studied. METHODS: This analysis included 609 participants from the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist) trial. Depressive symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9) at baseline and at 1-year, 2-year and 3-year intervals. Individual trajectory patterns based on PHQ-9 scores during the first 3 years were identified using latent class trajectory models, and their associations with clinical outcomes were evaluated using Cox regression models. RESULTS: Among the 609 participants, 316 (51.9%) were female, with a median age of 74 years (IQR: 66, 80). Four distinct depression trajectory patterns were identified: low (consistently low scores; 349, 57.3%), mild (sustained mild elevation; 110, 18.1%), high (sustained moderate-severe elevation; 52, 8.5%) and recurrent deterioration (high baseline scores, remission, then escalation; 98, 16.1%). According to the multivariate Cox model, recurrent deterioration was associated with a significantly greater risk of all-cause mortality (HR: 2.05; 95% CI 1.16, 3.64) than the low trajectory pattern. No significant differences were found among the low, mild and high trajectory groups. CONCLUSIONS: Four distinct depression trajectory patterns were identified among patients with HFpEF. Notably, patients who experienced a recurrent deterioration trajectory presented a significantly increased risk of all-cause mortality. Our findings highlight the importance of monitoring patients' depressive symptoms over time rather than focusing on a single timepoint. TRIAL REGISTRATION NUMBER: NCT00094302."}